Skip to content
healthcare.dev

Glyburide and Metformin Hydrochloride

NDC 57237-023, Glyburide and Metformin Hydrochloride, tablet, film coated, from Rising Pharma Holdings, Inc..

Product NDC
57237-023
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077870
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYBURIDE1.25 mg/1
  • METFORMIN HYDROCHLORIDE250 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
57237-023-0157237002301100 TABLET, FILM COATED in 1 BOTTLE (57237-023-01)
57237-023-0557237002305500 TABLET, FILM COATED in 1 BOTTLE (57237-023-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/372af566-d6ec-446f-88db-0b4cc83b577f

Use it

Look up 57237-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.